1994
DOI: 10.1007/bf00197523
|View full text |Cite
|
Sign up to set email alerts
|

Drug combination therapy of systemic lupus erythematosus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

1998
1998
2016
2016

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 14 publications
0
3
0
Order By: Relevance
“…Clinical benefits obtained by administering cyclosporine in combination with prednisone even in patients whose disease has failed to respond to a previous steroid therapy have been described (10,11), but no controlled trial has been reported fully until now. To compare the effectiveness of cyclosporine and azathioprine in the maintenance therapy of patients with lupus nephritis, we organized a multicenter, prospective, randomized, open, blinded-end point, controlled trial in which patients with active disease initially were treated with an induction therapy and then randomly assigned to low-dose prednisone plus cyclosporine or azathioprine.…”
mentioning
confidence: 99%
“…Clinical benefits obtained by administering cyclosporine in combination with prednisone even in patients whose disease has failed to respond to a previous steroid therapy have been described (10,11), but no controlled trial has been reported fully until now. To compare the effectiveness of cyclosporine and azathioprine in the maintenance therapy of patients with lupus nephritis, we organized a multicenter, prospective, randomized, open, blinded-end point, controlled trial in which patients with active disease initially were treated with an induction therapy and then randomly assigned to low-dose prednisone plus cyclosporine or azathioprine.…”
mentioning
confidence: 99%
“…Good results with this calcineurin inhibitor in association with steroids, cyclophosphamide, and methotrexate have been reported by Miescher et al in patients with lupus nephritis refractory to previous treatment (11). Other papers reported that cyclosporine induced remission in most patients with SLE membranous nephropathy, but relapse of proteinuria was frequent when the drug was withdrawn (12,13).…”
Section: Cyclosporinementioning
confidence: 86%
“…Fortunately, in our patients we limited the dose from the very beginning to less than 5 mg/kg per day. In combination with low doses of cortisone and MTX [70,71] this dose of CsA showed no or only insignificant signs of toxicity in 192 kidney biopsy specimens. Furthermore, longterm medication (15-20 years) did not lead to impairment of kidney function.…”
Section: Cyclophosphamidementioning
confidence: 92%